What's New on the FDA Drugs Site
June 15, 2016
- Comunicado de la FDA sobre la seguridad de los medicamentos La Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) advierte que se siguen recetando tabletas orales de Nizoral (ketoconazol) para usos no aprobados, incluso a fin de tratar infecciones en las uñas y en la piel; el uso de este medicamento está relacionado con la muerte de un paciente
- Drug Firm Annual Registration Status Download File (updated)
- Drug Firm Annual Registration Status (updated)
- Drugs@FDA Data Files (updated)
- FDA Drug Shortages
- Calcium Gluconate Injection (Updated - Currently in Shortage)
- Cefepime Injection (Updated - Currently in Shortage)
- Cefotetan Disodium Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Potassium Chloride Injection (Updated - Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated - Currently in Shortage)
- Tobramycin Injection (Updated - Currently in Shortage)
- Vancomycin Hydrochloride for Injection, USP (Updated - Currently in Shortage)
- National Drug Code Directory
- Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario